Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir marboxil in otherwise healthy infants with influenza-like illness
2018-002154-70Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of baloxavir marboxil in influenza, sponsored by Roche. Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started Jul 2019; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on 2018-002154-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002154-70.